日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

非小细胞肺癌软脑膜转移的演变格局:一项国际性、当代、多中心队列研究

Zheng, M M; Xia, Y; Pan, K; Sun, F; Tan, A C; Dong, X R; Tu, H Y; Tang, L B; Li, Y S; Yin, K; Borgeaud, M; Singhal, S; Zhu, E; Zhang, J; Nilsson, M; Wu, J; Gibbons, D L; Wakelee, H; Neal, J W; Lee, J; Vaporciyan, A A; Ringsurongkawong, W; Tran, H T; Zhang, R Z; Zhang, T; Zhou, Q; Zhong, W Z; Li, W; Zhang, Y C; Riess, J W; Addeo, A; Heymach, J V; Myall, N; Tan, D; Wu, Y L; Le, X

Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke: The OPTION Randomized Clinical Trial

替奈普酶治疗缺血性卒中后 4.5 至 24 小时内的急性非大血管闭塞:OPTION 随机临床试验

Ma, Gaoting; Mo, Ran; Zuo, Yingting; Ma, Qingfeng; Zhao, Guangjian; Yao, Xiaoxi; Liang, Ji; Zhou, Li; He, Yong; Long, Faqing; Yuan, Zhengzhou; Liu, Lei; Han, Guosheng; Tan, Yan; Ai, Zhibing; Cai, Chunsheng; Liu, Juan; Zhang, Liyong; Yang, Haihua; Yi, Tingyu; Li, Li; Fu, Yao; Zhang, Yanxing; Shao, Xiangzhong; Yu, Zhipeng; Wu, Saizhen; Du, Yanqiu; Mao, Lingqun; Guo, Hongling; Chen, Xufeng; Chen, Yifei; Zhao, Qiong; Chi, Liyi; Liu, Yi; Zhang, Haochun; Li, Guangzong; Meng, Shujuan; Wu, Yifan; Wu, Jieying; Jiang, Ziying; Lei, Shaoyuan; Gao, Daiquan; Zhong, Lianmei; Fiehler, Jens; Wang, Duolao; Nguyen, Thanh N; Saver, Jeffrey L; Hao, Junwei

Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer

癌症神经科学:癌症信号通路和新的治疗策略

Zhang, Sihui; Yuan, Lin; Lin, Ping; Yang, Gen; Zhou, Xikun; Xu, Jinfu; Wu, Min; Huang, Yongye

Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis

Claudin18.2特异性IL-7/XCL1修饰的CAR-T细胞在消化道癌症中的疗效和免疫调节作用:临床前和临床分析

Zhao, Xuan; Liu, Jinyan; Zhang, Zhen; Zhou, Yali; Jin, Shuiling; Zong, Hong; Wang, Feng; Song, Min; Zhong, Yali; Li, Qinglong; Pei, Bo; Yu, Yong; Gao, Ming; Ge, Wengang; Han, Lu; Ren, Jiangtao; Zhang, Yi

Signaling pathways and targeted interventions for precancers

癌前病变的信号通路和靶向干预

Yang, Jin; Wang, Shimeng; Li, Xin; Xu, Hongdan; Sun, Tongxu; Hu, Tao; Luo, Jingjing; Zhou, Hongmei

Visinin-like protein 1 disrupts calcium homeostasis and promotes atrial fibrillation in human and rodent models

视蛋白样蛋白1破坏钙稳态,并在人类和啮齿动物模型中促进心房颤动。

Xiong, Ke; Wang, Guanghua; Li, Desheng; Shao, Beihua; Chen, Zhiwen; Zou, Qicheng; Zhang, Xinrui; Dong, Yanru; Zhao, Xuxia; Yuan, Yixin; Xu, Hongtao; Liu, Yi; Liang, Dandan; Wang, Li; Zhou, Bin; Dong, Nianguo; Xie, Duanyang; Chen, Yi-Han

Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation

糖皮质激素通过抑制H4K12乳酸化作用,提高透明细胞肾细胞癌对HIF-2α抑制剂的敏感性。

Zhang, Kenan; He, Lin; Wang, Yizhou; Qin, Sen; Yu, Chunyu; Zheng, Enrun; Zhang, Zedan; Xu, Yawei; Chen, Xiaolin; Liu, Yanhua; Liu, Xiaoya; Guan, Sudun; Xia, Lu; Suo, Feiya; Pei, Fei; Du, Juan; Su, Yiran; Li, Yanze; Wu, Yu; Zhou, Xuehong; Zhou, Jingcheng; Cai, Lin; Tang, Xinjing; Zhang, Zheng; Shang, Yongfeng; Zhang, Qing; Gong, Kan; Sun, Luyang